WT1 and Nephroblastoma: Third, detection of certain mutations allows prediction and further screening of renal and extrarenal comorbidities and helps to avoid possible future complications, e.g., risk of Wilms’ tumor or gonadoblastoma in patients with WT1 mutations [31,32].